Results 31 to 40 of about 2,524 (176)

EPSTEIN-BARR VIRUS: CAUSES, CONSEQUENCES, DIAGNOSIS AND TREATMENT OF EPSTEIN-BARR VIRUS IN HUMAN [PDF]

open access: yesSanamed
The Epstein-Barr virus (EBV) belongs to the family of herpesviruses, subfamily Gammaherpesvirinae, and genus Lymphocryptovirus. Despite this classification, there are two serotypes of the Epstein-Barr virus, namely type A and type B.
Koprivica Marko
doaj   +1 more source

Immunosenescence and lymphomagenesis [PDF]

open access: yes, 2018
One of the most important determinants of aging-related changes is a complex biological process emerged recently and called \u201cimmunosenescence\u201d.
A Beheshti   +90 more
core   +1 more source

Epstein-Barr Virus Neurologic Complications

open access: yesPediatric Neurology Briefs, 2015
Investigators at the Karol Marcinkowski University of Medical Sciences, Poznan, Poland, analyzed the records of 194 children diagnosed with Epstein-Barr virus infection and having the viral capsid antigen IgM antibody.
J. Gordon Millichap
doaj   +1 more source

THE MOLECULAR MECHANISMS OF EPSTEINBARR VIRUS PERSISTENCE IN THE HUMAN ORGANISM [PDF]

open access: yesAnnals of Mechnikov's Institute, 2014
This review describes advances in molecular aspects of EBV infection and disease. We discuss the spectrum of clinical illness due to EBV persistent infection.
Volyanskiy A.Yu.   +8 more
doaj  

Epstein-Barr Virus and Multiple Sclerosis

open access: yesFrontiers in Immunology, 2020
Multiple sclerosis (MS) is a neurologic disease affecting myelinated nerves in the central nervous system (CNS). The disease often debuts as a clinically isolated syndrome, e.g., optic neuritis (ON), which later develops into relapsing-remitting (RR) MS,
Gunnar Houen   +4 more
doaj   +1 more source

Epstein-Barr virus: Current questions and challenges

open access: yesTumour Virus Research, 2021
Epstein-Barr virus (EBV) infects most people worldwide and persists for life due to complicated interplay between lytic infection and multiple types of latent infections. While usually asymptomatic, EBV is a causative agent in several types of cancer and
Lori Frappier
doaj   +1 more source

<p>Epidemiology, Outcome and Risk Factors Analysis of Viral Infections in Children and Adolescents Undergoing Hematopoietic Cell Transplantation: Antiviral Drugs Do Not Prevent Epstein–Barr Virus Reactivation</p>

open access: yesInfection and Drug Resistance, 2019
The analysis of epidemiology, risk factors and outcome of viral infections in children and adolescents after hematopoietic cell transplantation (HCT).In this multicenter nationwide study a total of 971 HCT procedures (741 allo-HCT; 230 auto-HCT) over a period of 6 years were analyzed.During this period 801 episodes of viral infections were diagnosed in
Krzysztof Czyzewski   +10 more
openaire   +7 more sources

Variation in the dynamics and performance of industrial innovation: what can we learn from vaccines and HIV vaccines? [PDF]

open access: yes, 2018
This article examines contingencies and constraints in problem-solving processes underlying technological change and industry evolution. It shows how learning through practice can help drive technical change but, when this is impeded, the ability to make
Yaqub, Ohid
core   +1 more source

Epstein-Barr Virus and Systemic Autoimmune Diseases

open access: yesFrontiers in Immunology, 2021
Epstein-Barr Virus (EBV) is an extremely successful human herpes virus, which infects essentially all human beings at some time during their life span. EBV infection and the associated immune response results in production of antibodies (seroconversion),
Gunnar Houen   +2 more
doaj   +1 more source

Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients [PDF]

open access: yes, 2019
Viral infections have a major impact on morbidity and mortality of immunosuppressed solid organ transplant (SOT) patients because of missing or failure of adequate pharmacologic antiviral treatment.
Amini, Leila   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy